Skip to content Accessibility statement

Funding boost for biological chemistry research

Posted on 21 January 2014

New funding is allowing researchers at the University of York to further develop software underpinning research in the pharmaceutical industry and academic laboratories worldwide.

Dr Kevin Cowtan, of the University's Structural Biology Laboratory, has been awarded a £470,000 five-year research fellowship from the industrial income of Collaborative Computational Project Number 4 in Protein Crystallography (CCP4), a project hosted by the Science & Technology Facilities Council (STFC).

CCP4 is a long-running project developing software used to determine the three-dimensional structures of biomolecules (proteins and nucleic acids) by macromolecular X-ray crystallography (MX). Crystallography is a technique which can provide the most detailed structural information about a molecule. Dr Cowtan also heads the York element of a successful consortium bid to the Biotechnology and Biological Sciences Research Council (BBSRC) for continued funding of CCP4.

Structures derived through MX make a key contribution to scientists' understanding of how proteins work, which provides the basis for applications in the pharmaceutical and biotechnology industries.

Dr Cowtan said: “MX is an important tool in drug development, enabling the detailed design of drugs tailored to alter the action of biomolecules by blocking or promoting the chemical processes which the target molecule performs.  X-ray structure determination requires intensive computational analysis, and the CCP4 software enables the biotech companies undertaking drug development to determine structures of protein-ligand complexes more effectively.”

The CCP4 team includes researchers from York, Newcastle, Kent, Leeds, Oxford and Cambridge, as well as the core group based at the STFC laboratory at Harwell. The software package, which was developed by a team including Dr Cowtan, is licensed nationally and internationally to industrial users in the pharmaceutical and biotechnology sectors.

Notes to editors:

  • An image of a double-helix of RNA, life’s information messenger, showing the result of an X-ray experiment (a mesh of electron density) and an atomic model built automatically using Dr Cowtan's software, is available from the University of York Press Office. (Contact pressoffice@york.ac.uk or 01904 322029.) Please credit Dr Kevin Cowtan
  • The Collaborative Computational Project Number 4 in Protein Crystallography (CCP4) is supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and coordinated at the Science and Technology Facilities Council (STFC) Rutherford Laboratory by the Computational Science and Engineering Department of STFC. It produces and supports a world-leading, integrated suite of programs that allows researchers to determine macromolecular structures by X-ray crystallography and other biophysical techniques.
     CCP4 was set up in 1979 by a consortium of academics to promote collaboration between researchers working in structural biology in the UK. As a community based resource, it supports academic, not for profit and profit research, and also aims to play a key role in the education and training of scientists in experimental structural biology.
  • More information on Dr Kevin Cowtan’s research at www.york.ac.uk/chemistry/staff/academic/a-c/kcowtan/
  • More information on the University of York's Structural Biology Laboratory at www.york.ac.uk/chemistry/research/ysbl/
  • More information on the University of York’s Department of Chemistry at www.york.ac.uk/chemistry

Contact details

Caron Lett
Press Officer

Keep up to date

 Subscribe to news feeds

 Follow us on Twitter